Birch Pollen Immunotherapy Leads to Differential Induction of Regulatory T Cells and Delayed Helper T Cell Immune Deviation

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Immunology

• Publication date

  2010-01-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.0901379PMID 20048125
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?

  2009cited by this paper
• Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?

  2009cited by this paper
• Assessment of Bet v 1-Specific CD4+ T Cell Responses in Allergic and Nonallergic Individuals Using MHC Class II Peptide Tetramers1

  2008cited by this paper
• Two year follow‐up of immunological response in mite‐allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration

  2008cited by this paper
• Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll‐like receptors

  2008cited by this paper
• Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR‐L interaction, IL‐10 and TGF‐β

  2008cited by this paper
• Peripherally Induced Treg: Mode, Stability, and Role in Specific Tolerance

  2008cited by this paper
• Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa.

  2008cited by this paper
• Cellular and Humoral Mechanisms of Immune Tolerance in Immediate-Type Allergy Induced by Specific Immunotherapy

  2008cited by this paper
• Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity.

  2008cited by this paper
• Allergenic pollen and pollen allergy in Europe

  2007influential reference
• Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.

  2007influential reference
• Grass Pollen Immunotherapy Induces an Allergen-Specific IgA2 Antibody Response Associated with Mucosal TGF-β Expression1

  2007cited by this paper
• Immune regulation by CD4+CD25+ T cells and interleukin‐10 in birch pollen‐allergic patients and non‐allergic controls

  2007cited by this paper
• The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis

  2006cited by this paper
• Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans

  2006cited by this paper
• CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

  2006influential reference
• Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

  2006influential reference
• Competence and competition: the challenge of becoming a long-lived plasma cell

  2006cited by this paper
• Allergen-specific immunotherapy with recombinant grass pollen allergens.

  2005cited by this paper
• Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity.

  2005cited by this paper
• Is Immunotherapy-Induced Birch-Pollen-Specific IgG4 a Marker for Decreased Allergen-Specific Sensitivity?

  2005cited by this paper
• Defective suppression of Th2 cytokines by CD4+CD25+ regulatory T cells in birch allergics during birch pollen season

  2004cited by this paper
• Mechanisms of immunotherapy: IgG revisited

  2004cited by this paper
• Differential Regulatory Capacity of CD25+ T Regulatory Cells and Preactivated CD25+ T Regulatory Cells on Development, Functional Activation, and Proliferation of Th2 Cells1

  2004cited by this paper
• The blocking activity of birch pollen-specific immunotherapy-induced IgG4 is not qualitatively superior to that of other IgG subclasses.

  2004cited by this paper
• Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease.

  2004cited by this paper
• High Dose Allergen Stimulation of T Cells from House Dust Mite-Allergic Subjects Induces Expansion of IFN-γ+ T Cells, Apoptosis of CD4+IL-4+ T Cells and T Cell Anergy

  2004cited by this paper
• Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells

  2004influential reference
• Grass Pollen Immunotherapy Induces Mucosal and Peripheral IL-10 Responses and Blocking IgG Activity1

  2004cited by this paper
• Prevalence and rate of diagnosis of allergic rhinitis in Europe

  2004cited by this paper
• A double‐blind, placebo‐controlled birch allergy vaccination study: inhibition of CD23‐mediated serum‐immunoglobulin E‐facilitated allergen presentation

  2004cited by this paper
• Mechanisms of immunotherapy.

  2004cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy

  2003influential reference
• Supporting Online Material

  2003cited by this paper
• Vaccination for birch pollen allergy. Induction of affinity-matured or blocking IgG antibodies does not account for the reduced binding of IgE to Bet v 1.

  2003cited by this paper
• To respond or not to respond: T cells in allergic asthma

  2003cited by this paper
• Allergen‐specific immunotherapy with a monophosphoryl lipid A‐adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy‐induced blocking antibodies

  2003cited by this paper
• Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy.

  2003influential reference
• Renaissance of the Blocking Antibody Concept in Type I Allergy

  2003cited by this paper
• [Application of the nasal provocation test on diseases of the upper airways. Position paper of the German Society for Allergology and Clinical Immunology (ENT Section) in cooperation with the Working Team for Clinical Immunology].

  2003cited by this paper
• Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production.

  2003cited by this paper
• Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

  2002cited by this paper
• The safety and efficacy of subcutaneous birch pollen immunotherapy – a one‐year, randomised, double‐blind, placebo‐controlled study

  2002cited by this paper
• Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.

  2001cited by this paper
• Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β

  2001cited by this paper
• Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood

  2001cited by this paper
• Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study

  2001cited by this paper
• Inhibition of IgE‐induced activation of human mast cells by IL‐10

  2001cited by this paper
• Changes in Cytokine Production In Vitro during the Early Phase of Birch‐Pollen Immunotherapy

  2000cited by this paper
• Allergen immunotherapy: does it work and, if so, how and for how long?

  2000cited by this paper
• Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: a study performed with purified recombinant pollen allergens.

  2000cited by this paper
• Prevalence and etiology of asthma.

  2000cited by this paper
• Immunotherapy in allergic rhinitis: a prevention for asthma?

  1999cited by this paper
• Changing prevalence of allergic rhinitis and asthma.

  1999cited by this paper
• The epidemic of allergy and asthma

  1999cited by this paper
• The kinetics of change in cytokine production by CD4 T cells during conventional allergen immunotherapy.

  1999cited by this paper
• Allergen immunotherapy: therapeutic vaccines for allergic diseases

  1998cited by this paper
• Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations.

  1998cited by this paper
• Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals.

  1998cited by this paper
• IgE versus IgG4 production can be differentially regulated by IL-10.

  1998cited by this paper
• Role of interleukin 10 in specific immunotherapy.

  1998cited by this paper
• Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper.

  1998cited by this paper
• A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

  1997cited by this paper
• T cells subsets and cytokines in allergic and non-allergic children. II. Analysis and IL-5 and IL-10 mRNA expression and protein production.

  1997cited by this paper
• Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy.

  1997cited by this paper
• Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T‐cell clones specific for Phi p 1, a major grass pollen allergen

  1997cited by this paper
• Interleukin-10 regulation in normal subjects and patients with asthma.

  1996cited by this paper
• Human IgG monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1.

  1996cited by this paper
• Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells

  1996cited by this paper
• Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

  1995cited by this paper
• Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures.

  1995cited by this paper
• Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991

  1995cited by this paper
• Grass pollen immunotherapy: efficacy and safety during a 4‐year follow‐up study

  1995cited by this paper
• Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

  1993cited by this paper
• Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart.

  1992cited by this paper
• Quantitative IgE- and IgG-subclass responses during and after long-term ragweed immunotherapy.

  1992cited by this paper
• Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-86.

  1990cited by this paper
• IgE and IgG antibodies of patients with allergy to birch pollen as tools to define the allergen profile of Betula verrucosa*

  1989cited by this paper
• A double-blind, placebo-controlled trial of polymerized whole ragweed for immunotherapy of ragweed allergy.

  1982cited by this paper
• The IgG subclasses of antibodies to grass pollen allergens produced in hay fever patients during hyposensitization

  1976cited by this paper

• Booster Injection with Birch Pollen Extract Activates B‐Cellular Memory Responses in Patients Having Completed Allergen Immunotherapy

  2025influential citation
• Tumor necrosis factor receptor 2 in allergen tolerance: a perspective view

  2025cites this paper
• Intradermally Administered Retinoic Acid or Vitamin D3-Loaded Liposomes Induce Tolerogenic Skin Dendritic Cells

  2025cites this paper
• Intratonsillar Immunotherapy: A Convenient and Effective Alternative to Subcutaneous Immunotherapy for Allergic Rhinitis

  2024cites this paper
• Precision care in the treatment of pediatric asthma

  2024influential citation
• T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy

  2023cites this paper
• A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1

  2023cites this paper
• Mechanisms and predictive biomarkers of allergen immunotherapy in the clinic.

  2023cites this paper
• Increase in the prevalence of follicular regulatory T cells correlates with clinical efficacy of sublingual immunotherapy with house dust mites

  2023cites this paper
• Comprehensive Study on Key Pollen Allergens

  2022cites this paper
• Comorbid allergic rhinitis and asthma: important clinical considerations

  2022cites this paper
• High-Efficiency Retroviral Transduction for Type 1 Regulatory T Cell Differentiation.

  2022cites this paper
• Research Progress of Regulatory T Cells in Atopic Dermatitis

  2022cites this paper
• Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunity

  2021cites this paper
• Evaluation of the Role of Autoimmunty in Allergic Rhinitis

  2021cites this paper
• Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy

  2021cites this paper
• Modulating Th2 Cell Immunity for the Treatment of Asthma

  2021cites this paper
• TCR/ITK Signaling in Type 1 Regulatory T cells.

  2021cites this paper
• Dc-specific aptamer decorated gold nanoparticles: A new attractive insight into the nanocarriers for allergy epicutaneous immunotherapy.

  2020cites this paper
• Chinese sweet tea (Rubus suavissimus) polyphenols attenuate the allergic responses in a Balb/c mouse model of egg allergy

  2020cites this paper
• Mechanisms of allergen-specific immunotherapy for allergic rhinitis and food allergies

  2020cites this paper
• Oral intervention of Lactobacillus pentosus S-PT84 attenuates the allergenic responses in a BALB/C mouse model of egg allergy.

  2020cites this paper
• A novel approach to ameliorate experimental milk allergy based on the oral administration of a short soy cross-reactive peptide.

  2020cites this paper
• Regulatory B cells control airway hyperreactivity and lung remodeling in a murine asthma model.

  2020cites this paper
• Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy

  2020cites this paper
• The role of Treg cell subsets in allergic disease.

  2020cites this paper
• Role of IL-35 in sublingual allergen immunotherapy

  2019cites this paper
• Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen‐specific Th2 response

  2019cites this paper
• Therapeutic effects of isomaltodextrin in a BALB/c mouse model of egg allergy

  2019cites this paper
• Diverse Mechanisms of Allergen Specific Immunotherapy

  2019cites this paper
• Allergen immunotherapy improves defective follicular regulatory T cells in patients with allergic rhinitis.

  2019cites this paper
• Induction of IgG2 and IgG4 B‐cell memory following sublingual immunotherapy for ryegrass pollen allergy

  2019cites this paper
• Transcriptome analysis and safety profile of the early-phase clinical response to an adjuvanted grass allergoid immunotherapy

  2019cites this paper
• Recent developments and highlights in immune monitoring of allergen immunotherapy

  2019cites this paper
• Effects of allergen-specific immunotherapy on peripheral blood regulatory T cells and serum concentrations of cytokines and immunoglobulins in horses with allergic dermatitis.

  2019cites this paper
• Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses

  2018cites this paper
• Sialylation of IgG antibodies inhibits IgG-mediated allergic reactions.

  2018cites this paper
• Antigen-specific regulatory T-cell responses against aeroantigens and their role in allergy

  2018influential citation
• Phenotype analyses of IL‐10‐producing Foxp3− CD4+ T cells increased by subcutaneous immunotherapy in allergic airway inflammation

  2018cites this paper
• Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT

  2018cites this paper
• Beyond Type 1 Regulatory T Cells: Co-expression of LAG3 and CD49b in IL-10-Producing T Cell Lineages

  2018cites this paper
• The B-cell side of Allergy and Chronic Inflammatory Disease: Studies on the source of IgE and IgG4

  2018cites this paper
• The biodiversity hypothesis and immunotolerance in allergy

  2018cites this paper
• Allergen‐specific immunotherapy induces regulatory T cells in an atopic dermatitis mouse model

  2018cites this paper
• The role of basophils as innate immune regulatory cells in allergy and immunotherapy

  2018cites this paper
• Blocking antibodies induced by allergen‐specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model

  2018influential citation
• The effect of regulatory T cells on tolerance to airborne allergens and allergen immunotherapy.

  2018cites this paper
• Biodiversität und Immuntoleranz in der Allergologie

  2018cites this paper
• Specific allergen immunotherapy for the treatment of allergic asthma: a review of current evidence.

  2017cites this paper
• The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis

  2017cites this paper
• Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers.

  2017cites this paper
• Investigating Immune Gene Signatures in Peripheral Blood from Subjects with Allergic Rhinitis Undergoing Nasal Allergen Challenge

  2017cites this paper
• T cell derived IL‐10 is dispensable for tolerance induction in a murine model of allergic airway inflammation

  2016cites this paper
• Research Techniques Made Simple: Monitoring of T-Cell Subsets using the ELISPOT Assay.

  2016cites this paper
• Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus

  2016cites this paper
• Analysis of antigen specific T cells in diabetes - Lessons from pre-clinical studies and early clinical trials.

  2016cites this paper
• Monitoring the epitope recognition profiles of IgE, IgG1, and IgG4 during birch pollen immunotherapy.

  2016cites this paper
• The adaptive immune system in atopic dermatitis and implications on therapy

  2016cites this paper
• Timothy grass pollen therapeutic vaccine: optimal dose for subcutaneous immunotherapy.

  2016cites this paper
• Immunoglobulin Glycosylation Effects in Allergy and Immunity

  2016cites this paper
• Therapeutic Immune Tolerance Approaches for the Treatment of Allergic Disease

  2016cites this paper
• Allergen immunotherapy for birch pollen-allergic patients: recent advances.

  2016cites this paper
• Allergenspezifische Immuntherapie: Aktueller Stand sowie neue Erkenntnisse und Entwicklungen

  2016cites this paper
• IL-10 and Regulatory T Cells Cooperate in Allergen-Specific Immunotherapy To Ameliorate Allergic Asthma

  2015cites this paper
• The efficacy of sublingual immunotherapy with Dermatophagoides farinae vaccine in a murine atopic dermatitis model

  2015cites this paper
• Allergen-Specific Tolerance Induction: Of Mice and Men

  2015cites this paper
• Adaptive Immunantworten und damit verbundene Triggerfaktoren bei atopischer Dermatitis

  2015cites this paper
• Strategies for the Modification and Evaluation of Allergenicity

  2015cites this paper
• Identification, caractérisation et validation de biomarqueurs liés à l’immunothérapie allergénique

  2015cites this paper
• Immune Responses to Allergens in Atopic Disease: Considerations for Bioinformatics

  2015cites this paper
• Effect of allergen-specific immunotherapy on CD4+ T cells

  2015cites this paper
• Clinical and cytokine responses to house dust mite sublingual immunotherapy.

  2015cites this paper
• Anti-human platelet antigen (HPA)-1a antibodies: For better or for worse

  2015cites this paper
• Modulation of immune responses by immunotherapy in allergic diseases.

  2014cites this paper
• Clinical Study Citrus / Cydonia Compositum Subcutaneous Injections versus Nasal Spray for Seasonal Allergic Rhinitis : A Randomized Controlled Trial on Efficacy and Safety

  2014cites this paper
• Association Between Specific Timothy Grass Antigens and Changes in Thelper 1 and 2 Cell Responses Following Specific Immunotherapy

  2014cites this paper
• Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).

  2014cites this paper
• New Strategies for Allergen T Cell Epitope Identification: Going beyond IgE

  2014cites this paper
• Association between specific timothy grass antigens and changes in TH1- and TH2-cell responses following specific immunotherapy.

  2014cites this paper
• Casein‐specific IL‐4‐ and IL‐13‐secreting T cells: a tool to implement diagnosis of cow's milk allergy

  2014cites this paper
• The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice

  2014cites this paper
• Reduction of the Number of Major Representative Allergens: From Clinical Testing to 3-Dimensional Structures

  2014cites this paper
• Characterisation of CD154+ T cells following ex vivo birch allergen stimulation defines a close relationship between T cell subsets in healthy volunteers

  2013cites this paper
• Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.

  2013cites this paper
• Examination of allergenic properties of recombinant banana glucanase (Musa acuminata)

  2013cites this paper
• Etude de la réponse lymphocytaire T dans l’allergie de l’enfant, au diagnostic et au cours de la désensibilisation

  2013cites this paper
• Regulatory cells and transplantation tolerance.

  2013cites this paper
• Therapeutic effects of β1, 4 mannobiose in a Balb/c mouse model of intranasally-induced pollen allergy.

  2013cites this paper
• Human Leukocyte Antigen-G and Regulatory T Cells during Specific Immunotherapy for Pollen Allergy

  2013cites this paper
• Changes in IL-10 and specific antibodies associated to successful Dermatophagoides pteronyssinus immunotherapy in children during the first year of treatment.

  2013cites this paper
• Series : Immunotherapy and Tolerance — Cutting Edge Allergen Immunotherapy and Tolerance

  2013cites this paper
• Kinetics, cross‐reactivity, and specificity of Bet v 1‐specific IgG4 antibodies induced by immunotherapy with birch pollen

  2013cites this paper
• ZAP70 expression in regulatory T cells in allergic rhinitis: effect of immunotherapy

  2013cites this paper
• Increased apoptosis of mononuclear cells in atopic patients - the effect of pollen season and stimulation with specific antigen Zwiększona apoptoza komórek jednojądrzastych u atopowych pacjentów - wpływ sezonu pylenia i pobudzenia swoistym antygenem

  2013cites this paper
• Allergen immunotherapy and tolerance.

  2013cites this paper
• Allergen Immunotherapy and

  2013cites this paper
• ALLERGY TO PETS; MOLECULAR APPROACHES FOR IMPROVED DIAGNOSTICS AND VACCINATION

  2012cites this paper
• Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs.

  2012cites this paper
• Immune regulation and modulation of allergy and inflammatory diseases

  2012cites this paper
• mRNA vaccination as a safe approach for specific protection from type I allergy

  2012cites this paper